アルベンダゾール市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00012948
  • Category : Life Sciences
  • No. of Pages : 150
今すぐ購入

市場紹介 アルベンダゾールは、高効率かつ低毒性の広域駆虫薬です。アルベンダゾールは、寄生虫の侵入に使用されるWHO承認の薬です。これは、アルベンダゾラムという名前でも呼ばれる広範囲の薬です。アルベンダゾールは経口投与される薬であり、医療システムに必要な重要で信頼できる薬として受け入れられています。主に子供や難民の間で寄生虫の感染が増加していることが、世界市場でアルベンダゾール薬の売上を押し上げている主な決定要因となっている。発展途上国の農村部は、線虫の蔓延に関する発生率の上昇グラフを示す最も発生しやすい地域です。 市場のダイナミクス アルベンダゾール市場は、虫害の発生率の増加と医療費の増加により成長しています。しかし、特に頭痛、吐き気、骨髄抑制、肝臓炎症などの薬の副作用は、世界のアルベンダゾール市場の成長を妨げると予想されます。さらに、異なるブランド名で製品を提供する複数の市場プレーヤーの存在により、アルベンダゾール市場の成長需要が促進されると予想されます。 市場範囲 「2031 年までのアルベンダゾール市場分析」は、世界市場動向分析に特に焦点を当てた、ヘルスケア業界の専門的で詳細な調査です。このレポートは、種類および用途ごとに詳細な市場分割を行い、アルベンダゾール市場の概要を提供することを目的としています。アルベンダゾール市場は、予測期間中に高い成長を遂げると予想されます。このレポートは、アルベンダゾール市場の主要企業の市場状況に関する主要な統計を提供し、市場の主要な傾向と機会を提供します。 市場分割 アルベンダゾール市場は、種類と用途に基づいて分割されています。タイプに基づいて、市場はカプセル、タブレットに分類されます。用途に基づいて、市場は蟯虫感染症治療薬、回虫感染症治療薬、その他の寄生虫感染症治療薬に分類されます。 このレポートは、定性的情報と定量的情報の両方を含む業界の詳細な概要を提供します。さまざまなセグメントに基づいたアルベンダゾール市場の概要と予測を提供します。また、次の 5 つの主要地域に関して、2021 年から 2031 年までの市場規模と予測推定値も提供します。北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、中南米。各地域別のアルベンダゾール市場は、後でそれぞれの国とセグメントごとにサブセグメント化されます。このレポートは、世界 18 か国の分析と予測、およびこの地域に広がる現在の傾向と機会をカバーしています。レポートは、アルベンダゾール市場に影響を与える需要側と供給側の両方の要因を分析し、予測期間中に市場に影響を与える市場のダイナミクス、つまり推進力、制約、機会、将来の傾向をさらに評価します。このレポートは、5 つの地域すべてに対する徹底的な PEST 分析も提供します。北米、ヨーロッパ、APAC、MEA、中南米は、これらの地域のアルベンダゾール市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後。 市場関係者 このレポートでは、有機的および無機的な成長戦略としてアルベンダゾール市場の主要な発展について取り上げています。さまざまな企業が、製品の発売、製品の承認、特許やイベントなどの有機的な成長戦略に焦点を当てています。市場で目撃された無機質な成長戦略は、買収、パートナーシップとコラボレーションでした。これらの活動により、市場プレーヤーのビジネスと顧客ベースの拡大への道が開かれました。アルベンダゾール市場の市場関係者は、世界市場でのアルベンダゾールの需要の高まりに伴い、将来的に有利な成長の機会があると予想されています。以下は、アルベンダゾール市場に従事するいくつかの企業のリストです。レポートには、アルベンダゾール市場の主要プレーヤーのプロフィールとSWOT分析および市場戦略も含まれています。さらに、このレポートは、企業概要、提供されるコンポーネントとサービス、過去 3 年間の財務情報、過去 5 年間の主な開発などの情報を含む業界の主要企業に焦点を当てています。
    • Jiangsu Quality Horizons Pharmtech Co., Ltd. • GlaxoSmithKline plc. • Supharma Chem • LASA Supergenerics Limited • KAMalle Pharmaceuticals • Fredun Group • 湖北中嘉化製薬株式会社 • AdvaCare Pharma • 華中製薬有限公司 (HPC) •  Hubei Keyi Pharmaceutical Co., Ltd.
Insight Partner の専任の調査分析チームは、高度な統計専門知識を持つ経験豊富な専門家で構成されており、既存の研究にさまざまなカスタマイズ オプションを提供しています。
  • 過去2年間の分析、基準年、CAGRによる予測(7年間)
  • PEST分析とSWOT分析
  • 市場規模価値/数量 - 世界、地域、国
  • 業界と競争環境
  • Excel データセット
albendazole-market-report-deliverables-img1
albendazole-market-report-deliverables-img2
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

よくある質問


What are the deliverable formats of the Albendazole Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report? 

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Which are the leading players operating in the Albendazole Market?

The leading players of the market are: Jiangsu Quality Horizons Pharmtech Co., Ltd., GlaxoSmithKline plc., Supharma Chem, LASA Supergenerics Limited, K.A.Malle Pharmaceuticals, Fredun Group, Hubei Zhongjia-chem pharmaceutical Co, Ltd, AdvaCare Pharma, Huazhong Pharmaceutical Co., Ltd (HPC), Hubei Keyi Pharmaceutical Co., Ltd.

What are the future trends of the Albendazole Market?

The future of the Albendazole market is promising. Ongoing research and development efforts are aimed at developing new formulations and combination therapies to improve efficacy and patient compliance. Furthermore, there is a trend in the potential of albendazole as a repurposed drug for other conditions, such as cancer and inflammatory bowel disease. However, challenges such as drug resistance and equitable access to treatment will have to be addressed for the market to continue growing.

What is the expected CAGR of the Albendazole Market?

Albendazole Market is expected to grow at a CAGR of 6.5% between 2023-2031

What are the driving factors impacting the Albendazole Market?

The Albendazole market is driven by many factors. The rising parasitic infections, especially in developing countries with poor sanitation, are a major driver. Albendazole's effectiveness against a wide range of parasites and its affordability make it a preferable treatment option. Government initiatives and public health programs to control parasitic diseases are further boosting demand. The awareness of health hazards caused by parasitic infections and the need for preventive measures is also contributing to the growth of the market.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Jiangsu Quality Horizons Pharmtech Co., Ltd.
2. GlaxoSmithKline plc.
3. Supharma Chem
4. LASA Supergenerics Limited
5. K.A.Malle Pharmaceuticals
6. Fredun Group
7. Hubei Zhongjia-chem pharmaceutical Co, Ltd
8. AdvaCare Pharma
9. Huazhong Pharmaceutical Co., Ltd (HPC)
10. Hubei Keyi Pharmaceutical Co., Ltd.
albendazole-market-cagr

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.